JP Stock MarketDetailed Quotes

4527 Rohto Pharmaceutical

Watchlist
  • 2719.0
  • +31.5+1.17%
20min DelayMarket Closed Dec 20 15:30 JST
642.17BMarket Cap20.11P/E (Static)

Rohto Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rohto Pharmaceutical H1 FY2025 Earnings Date

Currency：JPYNov 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
141.80B
139.08B
-2.72B
Miss Est.
+10.89%
+8.77%
-3.83%
EPS
--
56.47
--
-22.14%
Analyst Rating
Buy

Dec 18, 2024

Rohto Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 86.481B--
Feb 12, 20252025/Q3-- / 89.537B--
Nov 13, 20242025/Q270.726B / 71.022B--
Aug 7, 20242025/Q168.356B / 67.660B--
May 13, 20242024/Q469.677B / 71.304B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 86.481B--
Feb 12, 20252025/Q3-- / 89.537B--
Nov 13, 20242025/Q270.726B / 71.022B--
Aug 7, 20242025/Q168.356B / 67.660B--
May 13, 20242024/Q469.677B / 71.304B--

Unlock Free Earnings Estimates

Rohto Pharmaceutical Earnings Reports

  • Rohto Pharmaceutical: Confirmation letter

    Nov 13 20:17 ET

  • Rohto Pharmaceutical: Half Year Report - Term 89 (2024/04/01 - 2025/03/31)

    Nov 13 20:16 ET

  • Rohto Pharmaceutical: Overview of consolidated financial results for the fiscal year ending March 31, 2025 (4/1 to 9/30)

    Nov 13 01:30 ET

  • Rohto Pharmaceutical: Rohto Pharmaceutical Co., Ltd. 89th Interim Term (4/1 to 9/30) reference materials

    Nov 13 01:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 18, 2024

    Buy

    • Strong Buy

      33.33%

    • Buy

      55.56%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      11.11%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Price
    % Chg

    No Data